DGAP-News: MeVis Medical Solutions AG: MeVis' profitability further increased in the first quarter
(firmenpresse) - DGAP-News: MeVis Medical Solutions AG / Key word(s): Quarter
Results/Interim Report
MeVis Medical Solutions AG: MeVis' profitability further increased in
the first quarter
16.05.2013 / 07:30
---------------------------------------------------------------------
MeVis' profitability further increased in the first quarter
Further improvements in earnings with slightly declining sales
- Consolidated sales declined in the first three months as expected, by
9% to EUR 3.3 million (prev. year: EUR 3.6 million)
- Maintenance business contribution further increased to 47 % (prev.
year: 42 %)
- Earnings before interest and taxes (EBIT) up to EUR 0.8 million (prev.
year: EUR 0.6 million)
- Consolidated net profit increased significantly to EUR 0.8 million
(prev. year: EUR 0.1 million)
- Liquidity stable at EUR 8.6 million (December 31, 2012: EUR 8.7
million)
Bremen, May 16, 2013 - Today, MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a leading software provider for the medical imaging market,
announced its results for the first quarter of 2013.
As expected sales in the first quarter of 2013 came to EUR 3,318 k, down 9
% on the first quarter of 2012 (EUR 3,637 k). While license sales declined
by 21 % to EUR 1,589 k (prev. year: EUR 2,011 k), due in part to a package
of LungCAD licenses in the Other Diagnostics segment in the first quarter
of 2012, maintenance and service revenues again rose by 4 % to EUR 1,568 k
(prev. year: EUR 1,513 k).
Sales in the Digital Mammography segment went up slightly by 1 % to EUR
2,673 k (prev. year: EUR 2,650 k). In contrast, sales in the Other
Diagnostics segment declined by 35 % to EUR 645 k (prev. year: EUR 987 k).
Capitalized development expenses were lowered considerably by 41 % year on
year to EUR 410 k (prev. year: EUR 691 k).
Operating costs were again significantly reduced in the first quarter of
2013. As personnel expenses amounted to EUR 1,949 k, thus being 15 % down
on the prior-year quarter. Other operating expenses also decreased to EUR
484 k, corresponding to a 20 % reduction year on year.
After depreciation and amortization of EUR 495 k (44 % down year on year),
and due to the ongoing cost-cutting measures, EBIT (earnings before
interest and taxes) could be improved considerably to EUR 806 k (up a
significant 30 % on the prior-year figure of EUR 622 k). The EBIT margin
increased to 24 % (prev. year: 17 %).
An improvement in the financial result from EUR -90 k in the previous year
to EUR 102 k in the first quarter of 2013, results in pre-tax earnings in
the reporting period of EUR 908 k (prev. year: EUR 532 k). Taking into
account lower income tax expenses of EUR 106 k MeVis closed the first
quarter of the current financial year with a consolidated net profit of EUR
802 k (prev. year: EUR 108 k). Thus earnings per share amount to EUR 0.47
(prev. year: EUR 0.06).
Liquid funds remained stable in the reporting period and amounted to EUR
8,622 k on March 31, 2013 (December 31, 2012: EUR 8,665 k).
'On account of business development in the first three months of 2013, we
confirm our forecast for the current fiscal year, which expected sales in
2013 to be down slightly on the 2012 fiscal year. In our opinion the
consolidated earnings before interest and taxes (EBIT) is mainly influenced
the expected slight drop in sales, the lower level of capitalized
development expenses and the again slight reduction in personnel expenses.
Overall, we expect EBIT to decline slightly.' says Dr. Robert Hannemann,
CFO of MeVis Medical Solutions AG. 'In addition, we expect a positive cash
flow again in 2013, where in addition to the ongoing business the reduction
in trade receivables should make a significant contribution.'
'We now focus on the development and implementation of measures to generate
future sales growth so as to offset the trend of a declining new license
business.' added Marcus Kirchhoff, CEO of MeVis Medical Solutions AG. 'The
expansion of business relationships with existing industrial customers is
showing initial signs of success, which are expected to materialize into
small contributions to sales in the second half of the year. We have also
had initial talks with potential new industrial customers to gain
additional customers in our core business of selling software licenses and
therefore to modify and expand our product portfolio to meet the needs of
our customers. In order to build up the business with Internet-based
services, we will launch initial services on the market this year and
gradually expand these services. '
The financial reports of the company can be downloaded here:
http://www.mevis.de/ir_finanzberichte.html
End of Corporate News
---------------------------------------------------------------------
16.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir(at)mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
211352 16.05.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 16.05.2013 - 07:30 Uhr
Sprache: Deutsch
News-ID 260645
Anzahl Zeichen: 13596
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 203 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MeVis Medical Solutions AG: MeVis' profitability further increased in the first quarter"
steht unter der journalistisch-redaktionellen Verantwortung von
MeVis Medical Solutions AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
